MoneyWorks4Me

Nectar Lifesciences informs about post buyback public announcement

16 Jan 2026 Evaluate
Nectar Lifesciences has informed that Master Capital Services (Manager to the Buyback) has submitted a copy of Post Buyback Public Announcement for the attention of equity shareholders / beneficial owners of equity shares of Nectar Lifesciences (the Company).

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

11.27 0.53 (4.93%)
13-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.85
Dr. Reddys Labs. 1206.00
Cipla 1461.00
Lupin 2261.00
Zydus Lifesciences 1173.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: